結核の治療のためのデノボピューリン生物合成の標的化
Dirk A Lamprecht1,2, Richard J Wall3, Annelies Leemans4
1Janssen Global Public Health, LLC, Janssen Pharmaceutica NV, Antwerp, Belgium. dirk.lamprecht@uct.ac.za.
Nature
|June 18, 2025
まとめ
新薬候補であるJNJ-6640は,結核細菌の生存に不可欠な PurF酵素を効果的に抑制します. この発見は 薬剤耐性結核に対する 新しい戦略を提示しています
科学分野:
- 微生物学
- 薬物の発見
- 生物化学
背景:
- 結核 (TB) は,世界的に感染による死亡の主な原因です.
- 既存の治療法は 薬剤耐性菌株によって 困難に直面しています
- 新しい治療目標が 緊急に必要とされています
研究 の 目的:
- マイコバクテリアのデノボプリン生物合成経路を標的とする新しい小分子阻害剤を発見し,特徴づけること.
- 結核に対する鉛化合物 JNJ-6640の有効性と特異性を評価する.
- 結核の治療の新たな戦略として,デノボ・ピュリン生物合成を標的とする可能性を調査する.
主な方法:
- マイコバクテリアのデノボプリン生物合成の初期酵素である PurFを標的とする小分子阻害剤の識別と特徴づけ
- ミコバクテリアのPurFに対する殺菌活性と特異性を決定するインビトロ検査.
- 単細胞顕微鏡で DNA複製などのバクテリアの作用を観察します
- 人間とマウスの肺組織における核塩基濃度の測定
- 長期作用の注射剤を用いた in vivo 有効性試験
主要な成果:
- 鉛化合物であるJNJ-6640は,ナノモラー細菌滅菌作用を in vitroで実証した.
- JNJ-6640は,遺伝的および生化学的方法によって確認された,ミコバクテリアのPurFに対する高い選択性を示した.
- 肺組織における生理学的に重要な核塩基濃度は,PurF阻害を克服するには不十分であった.
- JNJ-6640の長時間作用の注射製剤による効果は,概念実証試験で確認されました.
- JNJ-6640はDNA複製に下流の影響を示した.
結論:
- JNJ-6640は,ミコバクテリアのPurFを標的とする有望なファーストインクラス阻害剤です.
- 新しい結核薬の開発には 新しい purin biosynthesisをターゲットにすることが 実行可能で新しい戦略です
- JNJ-6640は薬剤耐性結核の治療法を改善する可能性を秘めています.
さらに関連する動画
関連する概念動画
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Biosynthesis of Nucleic Acids
204
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
204
Pulmonary Tuberculosis IV
209
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
209
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis II
387
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
387
Pulmonary Tuberculosis III
458
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
458


